NDRG1 and osteosarcoma: On the other hand, abrogation of NDRG1 expression can sensitize osteosarcoma cells to combination therapy with combretastatin A-4 and chloroquine via suppression of autophagosome-lysosome fusion followed by promotion of apoptosis [74].